Eye Health News and Research

Latest Eye Health News and Research

In-car coach has strongest effect on drivers prone to distraction: Research

Although many states have banned using handheld cell phones at the wheel, a ban is difficult to enforce, and doesn't cover the growing number of gadgets now available.

12 Aug 2010

Scientists develop new imaging technique to create three-dimensional images of melanoma

Melanoma is one of the less common types of skin cancer but it accounts for the majority of the skin cancer deaths (about 75 percent).The five-year survival rate for early stage melanoma is very high (98 percent), but the rate drops precipitously if the cancer is detected late or there is recurrence.So a great deal rides on the accuracy of the initial surgery, where the goal is to remove as little tissue as possible while obtaining "clean margins" all around the tumor.So far no imaging technique has been up to the task of defining the melanoma's boundaries accurately enough to guide surgery.Instead surgeons tend to cut well beyond the visible margins of the lesion in order to be certain they remove all the malignant tissue.Two scientists at Washington University in St. Louis have developed technologies that together promise to solve this difficult problem.

12 Aug 2010

NeoStem, Schepens Eye Research Institute collaborate to develop therapies for AMD and Glaucoma

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that it has entered into a sponsored research agreement (SRA) with the Schepens Eye Research Institute, a charitable corporation of Massachusetts and an affiliate of Harvard Medical School.

12 Aug 2010

Shire announces divestiture of Daytrana to Noven Pharmaceuticals

Shire plc, the global specialty biopharmaceutical company, announced the divestiture of Daytrana (methylphenidate transdermal system) to Noven Pharmaceuticals, Inc. Daytrana, which is approved and marketed in the US for the treatment of Attention Deficit Hyperactivity Disorder in children and adolescents, will continue to be available for patients through Noven.

11 Aug 2010

Rxi Pharmaceuticals second-quarter net loss decreases to $2.1 million

RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today reported its financial results for the second quarter ended June 30, 2010.

11 Aug 2010

Survey finds prevalence of diabetic retinopathy high among U.S. adults

Nearly 30 percent of U.S. adults with diabetes over the age of 40 are estimated to have diabetic retinopathy, with about 4 percent of this population having vision-threatening retinopathy, according to a study in the August 11 issue of JAMA.

11 Aug 2010

OptiMedica to sell retina and glaucoma assets to Topcon

Global ophthalmic device company OptiMedica Corp. has announced that it has signed a definitive agreement to sell its retina and glaucoma assets to Topcon Corp., a strategic move that positions OptiMedica to focus exclusively on the continued development and commercialization of advanced technologies for the treatment of cataract.

11 Aug 2010

Noven enters agreement to acquire global rights to ADHD drug Daytrana from Shire

Noven Pharmaceuticals, Inc. today announced that it has entered into a Product and Trademark Acquisition Agreement with affiliates of Shire plc pursuant to which Noven will acquire global rights to Daytrana® (methylphenidate transdermal system) from Shire.

11 Aug 2010

China Sky One second-quarter 2010 total revenues up 26.7%

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China, today announced record financial results for the second quarter of 2010.

10 Aug 2010

Calif. considers reduction in funding for home care aides; Ill. union workers strike over health issues at uranium conversion plant

California, facing a $19.1 billion budget gap, is considering a reduction in funding that pays for home care aides for the disabled. It already cut funds last year. … Last month, the nation celebrated the 20th anniversary of the Americans With Disabilities Act … Now, though, gains made under the ADA are running into recession-battered state budgets.

10 Aug 2010

Scientific paper explains impact of visual cycle modulation in neurovascular retinopathy

Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that a scientific paper co-authored by Ryo Kubota, M.D., Ph.D., chairman, president and chief executive officer of Acucela, has been published in Experimental Eye Research. The paper, "Visual Cycle Modulation in Neurovascular Retinopathy" was also co-authored by scientists from Children's Hospital and Harvard Medical School in Boston and demonstrates for the first time the impact of treatment with a visual cycle modulator (VCM) on retinopathy in an immature eye.

10 Aug 2010

Array BioPharma fiscal 2010 revenue increases to $53.9 million

Array BioPharma Inc. today reported financial results for the fourth quarter and full year of fiscal 2010.

10 Aug 2010

ACADIA second-quarter net loss decreases to $4.3 million

ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the second quarter ended June 30, 2010.

10 Aug 2010

Scientists work towards creating a vaccine for Parkinson's disease

Nina Brown, 68, and millions of others with a debilitating neurological condition called Parkinson's disease are counting on researchers for a cure. At The University of Texas Health Science Center at Houston (UTHealth), protein chemists are working to develop a therapeutic vaccine.

10 Aug 2010

Alzheimer’s disease can now be predicted with 100% accuracy: Study

In a new development, Alzheimer's disease can now be predicted with up to 100 percent accuracy several years before its onset using three special marker proteins present in the spinal fluids. The study was published in the American Medical Association's Archives of Neurology.

9 Aug 2010

Clinical Data first-quarter gross revenue increases 52% to $6.2 million

Clinical Data, Inc. today announced operational and financial results for the first quarter ended June 30, 2010, noting key accomplishments including the acceptance of the Company's new drug application (NDA) for vilazodone by the U.S. Food and Drug Administration (FDA) and the successful completion of a public offering .

9 Aug 2010

Sparton Medical Systems acquires Delphi Medical's contract manufacturing business assets

Sparton Corporation, a supplier of complex and reliable electronic and electro-mechanical products, sub-assemblies and related services to the highly regulated Medical, Defense & Security, and Aerospace markets announces that on August 6, 2010 its wholly owned subsidiary, Sparton Medical Systems Colorado, LLC, completed its previously announced acquisition of certain assets related to the contract manufacturing business of Delphi Medical Systems, LLC. The all-cash transaction is valued at approximately $8.0 million.

9 Aug 2010

Scientists induce nerve tissue regeneration in patients with spinal cord injury

Researchers for the first time have induced robust regeneration of nerve tissue connections in injured adult spinal cord sites that control voluntary movement. These findings provide hope that it may be possible to design therapies for paralysis and other impairments of motor function arising from spinal cord injury.

9 Aug 2010

Fiber hair cosmetics safe and effective for women with moderate hair loss: Study

Hair is considered a woman's "crowning glory," but women with thinning hair and those with curly, textured hair may face considerable challenges in keeping their hair looking its best. Fortunately, there are many different hair care products, or hair cosmetics, that can help conceal thinning hair and also keep textured hair in check.

7 Aug 2010

Sucampo Pharmaceuticals second-quarter 2010 total revenue declines to $13.8 million

Sucampo Pharmaceuticals, Inc. today reported its consolidated financial results for the quarter and six months ended June 30, 2010.

7 Aug 2010

Eye Health News and Research

Latest Eye Health News and Research

In-car coach has strongest effect on drivers prone to distraction: Research

Scientists develop new imaging technique to create three-dimensional images of melanoma

NeoStem, Schepens Eye Research Institute collaborate to develop therapies for AMD and Glaucoma

Shire announces divestiture of Daytrana to Noven Pharmaceuticals

Rxi Pharmaceuticals second-quarter net loss decreases to $2.1 million

Survey finds prevalence of diabetic retinopathy high among U.S. adults

OptiMedica to sell retina and glaucoma assets to Topcon

Noven enters agreement to acquire global rights to ADHD drug Daytrana from Shire

China Sky One second-quarter 2010 total revenues up 26.7%

Calif. considers reduction in funding for home care aides; Ill. union workers strike over health issues at uranium conversion plant

Scientific paper explains impact of visual cycle modulation in neurovascular retinopathy

Array BioPharma fiscal 2010 revenue increases to $53.9 million

ACADIA second-quarter net loss decreases to $4.3 million

Scientists work towards creating a vaccine for Parkinson's disease

Alzheimer’s disease can now be predicted with 100% accuracy: Study

Clinical Data first-quarter gross revenue increases 52% to $6.2 million

Sparton Medical Systems acquires Delphi Medical's contract manufacturing business assets

Scientists induce nerve tissue regeneration in patients with spinal cord injury

Fiber hair cosmetics safe and effective for women with moderate hair loss: Study

Sucampo Pharmaceuticals second-quarter 2010 total revenue declines to $13.8 million

Genetics & Genomics - Second Edition eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in